Please try another search
© Reuters. FILE PHOTO: Chief Executive Officer of Barclays CS Venkatakrishnan walks outside the Treasury building, in London, Britain September 7, 2022. REUTERS/Hannah Mckay
By Lawrence White
LONDON (Reuters) -Barclays PLC said on Monday that Chief Executive C.S. Venkatakrishnan would undergo treatment for non-Hodgkin lymphoma, a type of cancer, adding that the condition is treatable and that he would keep working when possible.
The CEO, known inside the British bank as Venkat, said in a regulatory filing that doctors have said his prognosis is "excellent", with the treatment in New York expected to last 12 to 16 weeks.
Barclays (LON:BARC) has not appointed an interim chief executive, with Venkat and the lender's executive committee expected to continue running the company, said a spokesperson for the bank.
"During this period, the company will run normally, and I will continue to be actively engaged in managing it," Venkatakrishnan said in the filing.
Non-Hodgkin lymphoma is a cancer that develops in the lymphatic system, weakening the immune system, but most cases are considered "very treatable" according to information on the website of Britain's National Health Service.
Venkat, who is a U.S. citizen, may have to cut back on public engagements, such as a scheduled appearance at the World Economic Forum meetings in Davos next January, according to Barclays' spokesperson.
A former JPMorgan (NYSE:JPM) banker, Venkatakrishnan has endured a difficult first year in charge of Barclays since taking over from Jes Staley last November.
Barclays' strong investment banking results amid volatile markets have been overshadowed by an administrative blunder that saw it sell more securities in the United States than it was permitted to, leading to regulatory penalties and hefty losses.
Venkatakrishnan, who oversaw risk at the bank before taking on the top job, has called the error "preventable" and sought to reassure investors that investments in better controls mean a repeat will not happen.
Last month the bank beat analysts' expectations with a small rise in third quarter profit, but faces a tough economic outlook in its home market as the British economy shrinks and inflation rises.
Barclays shares were up 0.5% on Monday, against a broader FTSE 100 index down 0.5%.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review
Add a Comment
We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:
Enrich the conversation, don’t trash it.
Stay focused and on track. Only post material that’s relevant to the topic being discussed.
Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.
Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.